Dominant negative effects have been attributed to other missense variants in DNA repair proteins such as p53 and BRCA1 (Willis et al., 2004; Vaclova et al., 2016), re-affirming that loss-of-heterozygosity leading to loss-of-function is not the only path to increased cancer risk. This evidence concerns the gene TP53 and cancer.